4.6 Article

A Highly Conserved gp120 Inner Domain Residue Modulates Env Conformation and Trimer Stability

Journal

JOURNAL OF VIROLOGY
Volume 90, Issue 19, Pages 8395-8409

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.01068-16

Keywords

-

Categories

Funding

  1. Canada Foundation for Innovation Program Leader grant
  2. CIHR operating grants [119334, 134117]
  3. FRQS Establishment of Young Scientist grant [26702]
  4. FRQS AIDS and Infectious Diseases Network
  5. NIH [AI100645]
  6. Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID)
  7. NIAID, NIH [R01AI116274]
  8. Canada Research Chair on Retroviral Entry

Ask authors/readers for more resources

Previous studies have shown that highly conserved residues in the inner domain of gp120 are required for HIV-1 envelope glycoprotein (Env) transitions to the CD4-bound conformation (A. Finzi, S. H. Xiang, B. Pacheco, L. Wang, J. Haight, et al., Mol Cell 37:656-667, 2010, http://dx.doi.org/10.1016/j.molcel.2010.02.012;A. Desormeaux, M. Coutu, H. Medjahed, B. Pacheco, A. Herschhorn, et al., J Virol 87:2549-2562, 2013, http://dx.doi.org/10.1128/JVI.03104-12). Moreover, W69, a highly conserved residue located at the interface between layer 1 and layer 2 of the inner domain, was recently shown to be important for efficient Env recognition by CD4-induced (CD4i) antibodies capable of potent antibody-dependent cellular cytotoxicity (W. D. Tolbert, N. Gohain, M. Veillette, J. P. Chapleau, C. Orlandi, et al., 2016, Structure 24:697-709, http://dx.doi.org/10.1016/j.str.2016.03.005; S. Ding, M. Veillette, M. Coutu, J. Prevost, L. Scharf, et al., 2016, J Virol 90:2127-2134, http://dx.doi.org/10.1128/JVI.02779-15). We evaluated the contribution of the hydrophobicity of W69 to conformational changes of Env by replacing it with a series of residues with aliphatic or aromatic side chains of decreasing chain length. We have found that the hydrophobicity of residue 69 is important for Env processing, CD4 binding, and its transition to the CD4-bound conformation. The most deleterious effect was observed when W69 was replaced with alanine or glycine residues. However, the functions lost due to W69 mutations could be progressively restored with amino acids of increasing aliphatic chain length and fully recovered with residues bearing an aromatic ring. Interestingly, poor CD4 binding of W69A could be fully restored by introducing a compensatory mutation within layer 2 (S115W). Structural studies of HIV-1 gp120 core(e) W69A/S115W mutant bound to the CD4 peptide mimetic M48U1 and Fab of anti-cluster A antibody N60-i3 revealed no perturbations to the overall structure of the double mutant compared to the wild-type protein but identified higher mobility within the interface between layer 1 and layer 2, the bridging sheet region, and the CD4 binding site. IMPORTANCE HIV-1 Env transitions to the CD4-bound conformation are required for viral entry. Previous studies identified a highly conserved residue of the inner domain, W69, as being involved in these conformational transitions (A. Finzi, S. H. Xiang, B. Pacheco, L. Wang, J. Haight, et al., Mol Cell 37:656-667, 2010, http://dx.doi.org/10.1016/j.molcel.2010.02.012). Here, we show that W69, located at the interface between gp120 and gp41 in the PGT151-bound trimer, plays a critical role in the interprotomer signaling induced by CD4 binding. This new information might be useful in immunogen design.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Virology

Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4+ T Cell

Jeremie Prevost, Jonathan Richard, Romain Gasser, Halima Medjahed, Frank Kirchhoff, Beatrice H. Hahn, John C. Kappes, Christina Ochsenbauer, Ralf Duerr, Andres Finzi

Summary: HIV-1 Nef and Vpu are important for viral immune evasion, release, and replication. A new method was developed to detect these accessory proteins and their cellular substrates simultaneously. The study found that Vpu cannot compensate for the lack of a functional Nef, which is significant for studying ADCC responses using Nef-defective viruses.

JOURNAL OF VIROLOGY (2022)

Editorial Material Biochemistry & Molecular Biology

Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19

Philippe Begin, Jeannie Callum, Richard Cook, Erin Jamula, Yang Liu, Andres Finzi, Donald M. Arnold

NATURE MEDICINE (2022)

Correction Biochemistry & Molecular Biology

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial (vol 27, pg 2012, 2021)

Philippe Begin, Jeannie Callum, Erin Jamula, Richard Cook, Nancy M. Heddle, Alan Tinmouth, Michelle P. Zeller, Guillaume Beaudoin-Bussieres, Luiz Amorim, Renee Bazin, Kent Cadogan Loftsgard, Richard Carl, Michael Chasse, Melissa M. Cushing, Nick Daneman, Dana V. Devine, Jeannot Dumaresq, Dean A. Fergusson, Caroline Gabe, Marshall J. Glesby, Na Li, Yang Liu, Allison McGeer, Nancy Robitaille, Bruce S. Sachais, Damon C. Scales, Lisa Schwartz, Nadine Shehata, Alexis F. Turgeon, Heidi Wood, Ryan Zarychanski, Andres Finzi, Donald M. Arnold

NATURE MEDICINE (2022)

Article Virology

SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells

Shilei Ding, Damien Adam, Guillaume Beaudoin-Bussieres, Alexandra Tauzin, Shang Yu Gong, Romain Gasser, Annemarie Laumaea, Sai Priya Anand, Anik Prive, Catherine Bourassa, Halima Medjahed, Jeremie Prevost, Hugues Charest, Jonathan Richard, Emmanuelle Brochiero, Andres Finzi

Summary: Using the native full-length Spike protein expressed on the surface of infected cells in serological assays is effective in recapitulating findings and can be recognized by plasma from convalescent and vaccinated individuals.

VIRUSES-BASEL (2022)

Article Cell Biology

A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection

Guillaume Beaudoin-Bussieres, Yaozong Chen, Irfan Ullah, Jeremie Prevost, William D. Tolbert, Kelly Symmes, Shilei Ding, Mehdi Benlarbi, Shang Yu Gong, Alexandra Tauzin, Romain Gasser, Debashree Chatterjee, Dani Vezina, Guillaume Goyette, Jonathan Richard, Fei Zhou, Leonidas Stamatatos, Andrew T. McGuire, Hughes Charest, Michel Roger, Edwin Pozharski, Priti Kumar, Walther Mothes, Pradeep D. Uchil, Marzena Pazgier, Andres Finzi

Summary: Emerging evidence suggests that both neutralizing and Fc-mediated effector functions of antibodies are important for protection against SARS-CoV-2. A non-neutralizing antibody, CV3-13, with potent Fc-mediated effector functions, was found to bind to a specific epitope of the SARS-CoV-2 spike from a unique angle. In mouse experiments, the Fc-enhanced version of CV3-13 delayed virus spread, neuroinvasion, and death, and the combination of Fc-enhanced CV3-13 with a neutralizing antibody completely protected mice from lethal SARS-CoV-2 infection.

CELL REPORTS (2022)

Article Cell Biology

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern

Wenwe Li, Yaozong Chen, Jeemie Prevost, Irfan Ullah, Maoli Lu, Shang Yu Gong, Alexandra Tauzin, Romain Gasser, Dani Vezina, Sai Priya Anand, Guillaume Goyette, Debashree Chaterjee, Shilei Ding, William D. Tolbert, Michael W. Grunst, Yuxia Bo, Shijian Zhang, Jonathan Richard, Fei Zhou, Rick K. Huang, Lothar Esser, Allison Zeher, Marceline Cote, Priti Kumar, Joseph Sodroski, Di Xia, Pradeep D. Uchil, Marzena Pazgier, Andres Finzi, Walther Mothes

Summary: This study elucidates the structural basis and mode of action for two potent SARS-CoV-2 spike-neutralizing monoclonal antibodies. CV3-1 triggers shedding of the S1 subunit by binding to a loop structure in the receptor-binding domain (RBD), while CV3-25 inhibits membrane fusion by binding to an epitope in the stem helix region of the S2 subunit. Designing vaccine immunogens that incorporate conserved regions in the RBD and stem helix region could elicit pan-coronavirus protective immune responses.

CELL REPORTS (2022)

Article Immunology

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s

William D. Tolbert, Dung N. Nguyen, Marina Tuyishime, Andrew R. Crowley, Yaozong Chen, Shalini Jha, Derrick Goodman, Valerie Bekker, Sarah V. Mudrak, Anthony L. DeVico, George K. Lewis, James F. Theis, Abraham Pinter, M. Anthony Moody, David Easterhoff, Kevin Wiehe, Justin Pollara, Kevin O. Saunders, Georgia D. Tomaras, Margaret Ackerman, Guido Ferrari, Marzena Pazgier

Summary: The successful rhesusization of human mAbs targeting HIV-1 envelope epitopes in Non-Human Primates (NHPs) demonstrates the preservation of antibody specificity and function. This methodology is not only relevant for HIV-1 vaccine trials, but also applicable to antibodies for various other purposes.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19

Thomas J. Esparza, Yaozong Chen, Negin P. Martin, Helle Bielefeldt-Ohmann, Richard A. Bowen, William D. Tolbert, Marzena Pazgier, David L. Brody

Summary: NIH-CoVnb-112, a potent single-domain nanobody specific for the receptor-binding domain (RBD) of SARS-CoV-2, has been found to have broad in vitro neutralization capability against variant SARS-CoV-2 pseudoviruses. In an in vivo pilot study, nebulized delivery of NIH-CoVnb-112 effectively reduced weight loss, viral burden, and lung pathology in a Syrian hamster model of COVID-19. These findings support the further development of NIH-CoVnb-112 as a potential adjunct therapeutic for SARS-CoV-2 infection.
Article Microbiology

Bma-LAD-2, an Intestinal Cell Adhesion Protein, as a Potential Therapeutic Target for Lymphatic Filariasis

Alexander F. Flynn, Rebekah T. Taylor, Marzena E. Pazgier, Sasisekhar Bennuru, Alyssa R. Lindrose, Spencer L. Sterling, C. Paul Morris, Brynna Gleeson, Tim K. Maugel, Thomas B. Nutman, Edward Mitre

Summary: Lymphatic filariasis is a global disease caused by parasitic nematodes that affect millions of people. Identifying new drug and vaccine targets in adult filariae could aid elimination efforts. Bma-LAD-2 was identified as an essential protein for adult Brugia malayi, making it a potential therapeutic target.
Article Multidisciplinary Sciences

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities

Yaozong Chen, Lulu Sun, Irfan Ullah, Guillaume Beaudoin-Bussieres, Sai Priya Anand, Andrew P. Hederman, William D. Tolbert, Rebekah Sherburn, Dung N. Nguyen, Lorie Marchitto, Shilei Ding, Di Wu, Yuhong Luo, Suneetha Gottumukkala, Sean Moran, Priti Kumar, Grzegorz Piszczek, Walther Mothes, Margaret E. Ackerman, Andres Finzi, Pradeep D. Uchil, Frank J. Gonzalez, Marzena Pazgier

Summary: Researchers developed a bivalent ACE2-Fc with enhanced recognition of SARS-CoV-2 and improved antibody effector functions. In mouse models, this ACE2-Fc delayed death and effectively treated lethal SARS-CoV-2 infection through neutralization and effector functions.

SCIENCE ADVANCES (2022)

Article Cell Biology

Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity

Annemarie Laumaea, Lorie Marchitto, Shilei Ding, Guillaume Beaudoin-Bussieres, Jeremie Prevost, Romain Gasser, Debashree Chatterjee, Gabrielle Gendron-Lepage, Halima Medjahed, Hung-Ching Chen, Amos B. Smith III, Haitao Ding, John C. Kappes, Beatrice H. Hahn, Frank Kirchhoff, Jonathan Richard, Ralf Duerr, Andres Finzi

Summary: The conformation of HIV-1 envelope (Env) determines the susceptibility of infected CD4(+) T cells to antibody-dependent cellular cytotoxicity (ADCC). The downregulation of CD4 on infected macrophages by Nef, Vpu, and Env has a lesser impact on Env conformation and ADCC sensitivity compared to CD4(+) T cells. However, treatment of infected macrophages with small CD4 mimetics exposes vulnerable CD4-induced Env epitopes and sensitizes them to ADCC.

CELL REPORTS (2023)

Editorial Material Microbiology

Multitasking to prevent viral haemorrhagic fevers

Jeremie Prevost, Bryce M. Warner, David Safronetz

NATURE MICROBIOLOGY (2023)

Article Biotechnology & Applied Microbiology

Digoxin is a potent inhibitor of Bunyamwera virus infection in cell culture

Beatriz Pacheco, Alberto Fernandez-Oliva, Moises Garcia-Serradilla, Cristina Risco

Summary: In this study, the antiviral capacity of four repurposed drugs against BUNV infection was tested. Digoxin showed the strongest inhibitory effect on BUNV infection in Vero and HEK293T cells, as it reduced viral protein expression, affected the cell cycle, and altered mitochondrial morphology. The inhibition of the Na+/K+ ATPase by digoxin played a key role in its antiviral activity.

JOURNAL OF GENERAL VIROLOGY (2023)

Article Multidisciplinary Sciences

Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir

Jeremie Prevost, Yaozong Chen, Fei Zhou, William D. Tolbert, Romain Gasser, Halima Medjahed, Manon Nayrac, Dung N. Nguyen, Suneetha Gottumukkala, Ann J. Hessell, Venigalla B. Rao, Edwin Pozharski, Rick K. Huang, Doreen Matthies, Andres Finzi, Marzena Pazgier

Summary: Resistance to the HIV-1 entry inhibitor temsavir is not solely determined by residue 375, but also involves other residues within the gp120 inner domain layers. The resistance is mediated by crosstalk between residue 375 and the inner domain layers. Additionally, temsavir has the ability to adjust its binding mode to accommodate changes in Env conformation, contributing to its broad antiviral activity.

NATURE COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120

Jonathan Richard, Jeremie Prevost, Catherine Bourassa, Nathalie Brassard, Marianne Boutin, Mehdi Benlarbi, Guillaume Goyette, Halima Medjahed, Gabrielle Gendron-Lepage, Fleur Gaudette, Hung-Ching Chen, William D. Tolbert, Amos B. Smith, Marzena Pazgier, Mathieu Dube, Andrew Clark, Walther Mothes, Daniel E. Kaufmann, Andres Finzi

Summary: While HIV-1-mediated CD4 downregulation protects infected cells from ADCC, shed gp120 binds to uninfected bystander CD4+ T cells, sensitizing them to ADCC mediated by HIV+ plasma and triggering a cytokine burst. Temsavir, an HIV-1 attachment inhibitor, not only prevents gp120-CD4 interaction and alters Env antigenicity, but also blocks the immunomodulatory activities of shed gp120. Temsavir protects uninfected bystander CD4+ cells from ADCC responses and cytokine burst by preventing gp120 interaction, reducing shedding, and altering antigenicity.

CELL CHEMICAL BIOLOGY (2023)

No Data Available